Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age25-75
SponsorGeorgetown University
About this trial
The investigators will conduct a 2-arm 6-month randomized clinical controlled trial to evaluate the effectiveness of an oral Telehealth Intervention (THI) in preventing cancer-related oral complications, improving oral health maintenance and oral health related quality of life, and reducing systemic inflammation compared to Usual Care (UC) among unselected cancer survivors.
Eligibility criteria
Qualifiers
male and female cancer survivors who are either ≥ 6 months after competing primary therapy for cancer treatment (N=100)
between 25-75 years of age
all race/ethnic groups
own a smart phone.
Disqualifiers
all head and neck/oral cancer survivors
less then 25 years and older than 75 years of age
recurrence/second cancers or undergoing treatment
unable to provide informed consent.
Trial design
Treatments tested in this trial
- Telehealth Intervention (THI)
Treatment groups
100 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov